ArticlePathogens and global health2023

Use of Sotrovimab in a cohort of pregnant women with a high risk of COVID 19 progression: a single-center experience.

Luisa Frallonardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.